Business
Delivery man with boxes
Getty Images
DEAL WITH IT

It’s Amazon Prime Day versus Walmart Deals in a retail discount showdown

Walmart has been powering through the e-commerce world, bringing in $79 billion in revenue last year and growing explosively... just like Amazon in its prime.

Claire Yubin Oh

When e-commerce titans clash, the ground shakes, websites take longer to load, and (maybe) you get a bargain on that tablet you’ve had your eye on. That’s what could happen as Amazon and Walmart’s flagship annual discount periods are pitting the retail giants head-to-head.

Double dating

This year’s Amazon Prime Day promotion will start from July 8 to 11, overlapping with the “Walmart Deals” sale, which runs from July 8 to 13. For the first time, Amazon has also extended its two-day Prime Day(s) sale from two to four days — a change Walmart answered by stretching its own event from four days to six.

Annual discount periods are a significant revenue driver for both online and brick-and-mortar retailers, but they also help platforms stay top of mind for consumers.

This year, Amazon is expected to sell $21 billion worth of goods during its 96-hour extended Prime Day, per Bank of America, a staggering 60% jump on last year’s effort. 

Walmart and Amazon's e-commerce
Sherwood News

Amazon has long dominated the world’s online shopping landscape, but rival Walmart, whose US e-commerce business raked in $79 billion in revenue last year, has been catching up in a daunting, precedented speed — similar to Amazon’s explosive growth in the late 2000s and early 2010s. With a fleet of 4,600 stores as its online unit’s backbone, Walmart’s promotion this year will also feel a little like Amazon’s, with its Prime-like Walmart+ subscription at the center of its discounted period, as members get early access from July 7.

It’s Amazon vs. Walmart. The winner? Maybe bargain-hunting consumers. The losers? Any non-billion-dollar online stores trying to sell stuff over the next week.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.